Delivery Order SPE2DB20D3303-SPE2DB25FA2GJ
- Not listed
- The Defense Logistics Agency awarded a $6,760.14 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lonsurf (20 mg-8.19 mg tablets) in quantities of 40 units. This is a firm fixed price contract with an ultimate completion date of August 12, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be...
- This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug LONSURF 15 MG-6.14 MG TABLET 20S. The contract has a ceiling value of $10,156.60 and a period of performance through April 8, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LONSURF 20 MG-8.19 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $12,712.48 and a period of performance ending on July 23, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG tablets. The $8,531.96 firm-fixed-price contract has an ultimate completion date of October 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
- The Defense Logistics Agency awarded a $6,166.42 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 40 tablets of Lonsurf 20 mg-8.19 mg for cancer treatment. To be performed at the prime contractor's facility in Conshohocken, Pennsylvania, the order is for the delivery of the specified pharmaceutical product between September 13 and October 4, 2023. Amerisourcebergen will fulfill the delivery order as the prime contractor, with the Defense Logistics Agency...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $9,086.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561503738 LONSURF 15 MG-6.14 MG tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 40 tablets of LONSURF to its place of performance in Conshohocken, Pennsylvania by August 4, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics support in both...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is for the supply of the drug LONSURF 15 MG-6.14 MG TABLET 40S. The contract has an ultimate completion date of April 4, 2025 and a firm fixed price pricing type. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,599.25 fixed-price delivery order contract is for the provision of LONSURF 20 MG-8.19 MG TABLET 60S, a specialty pharmaceutical product. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2GJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9 billion prime vehicle designated as SPE2DX that runs through December 2026 and serves as the primary global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor headquartered in Conshohocken, Pennsylvania, with extensive experience supplying specialized medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal procurement portfolio demonstrates consistent capability in delivering brand-name and generic pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains under competitively awarded contracts. This delivery order for LONSURF, an oncology medication, exemplifies the vendor's role in supporting military medical supply chain requirements through the DLA Troop Support Medical platform.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 8/7/25 |